Clinical efficacy and lack of toxicity of allopurinol (NSC-1390) given intravenously.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D000493:Allopurinol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001806:Blood Urea Nitrogen; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D007945:Leukemia, Lymphoid / Q000150:complications; D007951:Leukemia, Myeloid / Q000150:complications; D015470:Leukemia, Myeloid, Acute / Q000150:complications; D008297:Male; D008875:Middle Aged; D014527:Uric Acid / Q000097:blood*
D014527:Uric Acid; D000493:Allopurinol; D000469:Alkaline Phosphatase